WMSA
ICPT

Weiss Multi-Strategy Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,000
Closed -$559K – 662
2019
Q1 		$559K Buy
+5,000
New +$546K 0.01% 431

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ICPT Position: Q3 2020 in Review

Weiss Multi-Strategy Advisers sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 10,353 shares — an estimated $496K sold.

Weiss Multi-Strategy Advisers first reported a position in ICPT in Q2 2013 and held it in 21 quarters. The position peaked at $9.63M in Q1 2014. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 10,353 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $496K.
  • Weiss Multi-Strategy Advisers first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 21 quarters.
  • Weiss Multi-Strategy Advisers's Intercept Pharmaceuticals, Inc. position peaked at $9.63M in Q1 2014.
  • 177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2020, filed 16 Nov 2020.